Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: cipro attending: chief complaint: shortness of breath major surgical or invasive procedure: 1. percutaneous aortic valve replacement with a corevalve 26-mm device, model number mcs-p3-640, serial number . 2. balloon aortic valvuloplasty. 3. ascending aortography. history of present illness: 81f with critical calcific as ( 0.7cm2), af on coumadin (last dose 2/17), s/p ppm for for bradycardia/prolonged qt admitted for iv heparin therapy prior to scheduled percutaneous avr scheduled for tues . the patient describes that she has been becoming progressively short of breath over the last few months. per her , she is barely able to get out of the bed without becoming winded. she notes that she has "weak legs" and has to stop and rest while walking. she denies any chest pain, palpitations, nausea, diaphoresis associated with her shortness of breath with exertion. she denies lightheadedness, loss of vision, or any recent falls. on review of systems, she denies any prior history of stroke, tia, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, cough, hemoptysis. she denies recent fevers, chills or rigors. she denies exertional buttock or calf pain. all of the other review of systems were negative. . cardiac review of systems is notable for absence of chest pain, dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, palpitations, syncope or presyncope. past medical history: 1. cardiac risk factors: dyslipidemia, hypertension 2. cardiac history: -cabg: none -pacing/icd: - sensia sedr01 dual chamber pacemaker with 100% v-paced. 3. other past medical history: - l femur fracture s/p orif on - as, valve area 0.7 on tte in - acute on chronic diastolic chf - atrial fibrillation - rotator cuff (left) - pulmonary hypertension - hypertension - hyperlipidemia - history of gi bleeding upper and lower endoscopy with no findings. coumadin was discontinued, but eventually resumed with no subsequent bleeding. - carotid stenosis/ 80-99% right carotid stenosis, 60-69% left carotid stenosis. - h/o delirium - r eye blindness social history: the patient lives with her daughter ( ) and 4 grandchildren in , ma. at home, help with her medications. retired former state employee (worked at the state mental hospital). has another daughter and other family in the area. denies smoking history, no alcohol use. no illicit drugs. family history: no family history of early mi, arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise non-contributory. physical exam: general: wdwn in nad. oriented x3. mood, affect appropriate. heent: ncat. sclera anicteric. perrl, eomi. conjunctiva were pink, no pallor or cyanosis of the oral mucosa. no xanthalesma. neck: supple with jvp of 6 cm. cardiac: pmi located in 5th intercostal space, midclavicular line. rr, normal s1, s2. 3/6 sem heard best lusb. no thrills, lifts. no s3 or s4. lungs: no chest wall deformities, scoliosis or kyphosis. resp were unlabored, no accessory muscle use. ctab, no crackles, wheezes or rhonchi. abdomen: soft, ntnd. no hsm or tenderness. abd aorta not enlarged by palpation. no abdominial bruits. extremities: no c/c/e. no femoral bruits. skin: no stasis dermatitis, ulcers, scars, or xanthomas. pulses: right: carotid 2+ femoral 2+ popliteal 2+ dp 2+ pt 2+ left: carotid 2+ femoral 2+ popliteal 2+ dp 2+ pt 2+ pertinent results: echocardiogram conclusions the left atrium is normal in size. there is mild symmetric left ventricular hypertrophy. the left ventricular cavity is unusually small. regional left ventricular wall motion is normal. overall left ventricular systolic function is normal (lvef>55%). the right ventricular cavity is mildly dilated with borderline normal free wall function. an aortic corevalve prosthesis is present. the transaortic gradient is normal for this prosthesis. trace aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. mild to moderate (+) mitral regurgitation is seen. the tricuspid valve leaflets are mildly thickened. moderate to severe tricuspid regurgitation is seen. there is moderate pulmonary artery systolic hypertension. there is no pericardial effusion. compared with the prior study (images reviewed) of , the right ventricle is probably slightly more dilated and hypokinetic than on prior study (the rv was probably mildly dilated and hypokinetic on the prior study, although reported as normal). degree of tricuspid regurgitation is similar. estimated pulmonary artery pressures are slightly lower. the corevalve appears in good position with normal gradients. admission labs: 03:14am blood wbc-5.0 rbc-3.43* hgb-10.4* hct-30.8* mcv-90 mch-30.4 mchc-33.8 rdw-13.7 plt ct-226 03:14am blood pt-16.8* ptt-150* inr(pt)-1.5* 03:14am blood glucose-90 urean-22* creat-1.8* na-137 k-5.4* cl-104 hco3-23 angap-15 03:35pm blood alt-21 ast-39 ck(cpk)-25* alkphos-73 totbili-0.2 03:35pm blood probnp-4007* discharge labs: 04:04am blood wbc-4.9 rbc-3.18* hgb-9.9* hct-29.7* mcv-93 mch-31.0 mchc-33.3 rdw-14.8 plt ct-228 04:04am blood plt ct-228 04:04am blood pt-16.0* ptt-27.9 inr(pt)-1.4* 04:04am blood glucose-99 urean-21* creat-1.2* na-141 k-3.6 cl-103 hco3-28 angap-14 radiology report chest (pa & lat) study date of 11:57 am final report: in comparison with the study of , there is some mild engorgement of pulmonary vessels suggesting some increasing pulmonary venous pressure in this patient with enlargement of the cardiac silhouette and dual-channel pacemaker device in place. corevalve placement is again noted and the central catheter remains in place. brief hospital course: 81f with pmh aortic stenosis presents for percutaneous aortic valve replacement. pt was admitted preoperatively on for heart failure optimization and iv heparin bridge. she was taken to the operating room on for: 1. percutaneous aortic valve replacement with a corevalve 26-mm device, model number mcs-p3-640, serial number . 2. balloon aortic valvuloplasty. 3. ascending aortography. she tolerated the procedure well and was trasferred from the operating room to the cardiac surgery icu in stable condition. the patient woke from anesthesia neurologically intact and was extubated. she remained in the icu for monitoring until pod***. from the icu she was transferred to the cardiac stepdown floor, while on the floor the patient was noted to be in acute pulmonary edema, she was agressively diuresed and responded appropriately. she was seen by physical therapy who worked with the patient to increase her strenghtth and mobility. it should be noted that pre operatively the patient was treated for a urinary tract infection. a repeat urine culture revealed a subsequent urinary tract infection with escherichia coli. and enterococcus sp.. she was seen by the infectious disease service for recommended antibiotic coverage, they felt there was a contaminated culture. the urine culture was repeated and was negative. on pod10 she was discharged home with visiting nurses. medications on admission: warfarin - 4 mg tablet mo-fri, 6 mg on sat (last dose 2/17, last inr 1.5 on ) folic acid - (prescribed by other provider) - 1 mg tablet - 1 tablet(s) by mouth once a day furosemide - (prescribed by other provider) - 20 mg tablet - 2 tablet(s) by mouth daily losartan - 50 mg tablet - 1 tablet(s) by mouth daily metoprolol tartrate - 25 mg tablet - tablet(s) by mouth twice daily mirtazapine - (prescribed by other provider) - 30 mg tablet - 1 tablet(s) by mouth once a day pantoprazole - (prescribed by other provider) - 40 mg tablet, delayed release (e.c.) - 1 tablet(s) by mouth twice daily potassium chloride - (prescribed by other provider) - 20 meq tab sust.rel. particle/crystal - 1 tab(s) by mouth twice a day simvastatin - (prescribed by other provider) - 20 mg tablet - 1 tablet(s) by mouth daily spironolactone - 25 mg tablet - 1 tablet(s) by mouth daily tramadol - (prescribed by other provider) - 50 mg tablet - 1 tablet(s) by mouth twice a day calcium-mag-vit b6-d3-minerals - (prescribed by other provider) - dosage uncertain cyanocobalamin (vitamin b-12) - (prescribed by other provider) - dosage uncertain ferrous sulfate - (prescribed by other provider) - 325 mg (65 mg iron) tablet - one tablet(s) by mouth daily magnesium oxide - 400 mg tablet - 2 tablet(s) by mouth daily discharge medications: 1. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). 2. mirtazapine 30 mg tablet sig: one (1) tablet po hs (at bedtime). 3. simvastatin 10 mg tablet sig: two (2) tablet po daily (daily). disp:*30 tablet(s)* refills:*1* 4. ferrous sulfate 300 mg (60 mg iron) tablet sig: one (1) tablet po daily (daily). 5. acetaminophen 325 mg tablet sig: 1-2 tablets po q6h (every 6 hours) as needed for fever/pain. 6. tramadol 50 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for pain. disp:*30 tablet(s)* refills:*0* 7. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*1* 8. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q12h (every 12 hours). 9. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 10. warfarin 1 mg tablet sig: as directed to keep inr 2-2.5 tablets po once a day: resume pre procedure coumadin schedule/dosing. 11. furosemide 40 mg tablet sig: one (1) tablet po twice a day. disp:*60 tablet(s)* refills:*2* 12. aldactone 25 mg tablet sig: one (1) tablet po once a day. 13. potassium chloride 10 meq tablet extended release sig: two (2) tablet extended release po once a day. disp:*60 tablet extended release(s)* refills:*2* 14. cozaar 25 mg tablet sig: one (1) tablet po once a day. discharge disposition: home with service facility: home health care discharge diagnosis: as chr af,ppm,orif lt hip, gibleed past surgical history: ppm,hipsx discharge condition: alert and oriented x3 nonfocal ambulating, gait steady with walker discharge instructions: see attached discharge instructions. if you have questions that are not answered by these instructions, please call the integrated aortic clinic at . followup instructions: provider: , md phone: date/time: 10:40 provider: clinic phone: date/time: 11:00 provider: , md phone: date/time: 11:40 labs: pt/inr coumadin for atrial fibrillation goal inr- 2-2.5 first draw- day after discharge then please do inr checks monday, wednesday, and friday for 2 weeks then decrease as directed by dr., a. procedure: combined right and left heart cardiac catheterization open and other replacement of aortic valve aortography percutaneous balloon valvuloplasty central venous catheter placement with guidance diagnoses: hyperpotassemia urinary tract infection, site not specified congestive heart failure, unspecified unspecified essential hypertension atrial fibrillation acute on chronic diastolic heart failure hematoma complicating a procedure aortic valve disorders other chronic pulmonary heart diseases other and unspecified hyperlipidemia atrioventricular block, complete cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure long-term (current) use of anticoagulants cardiac pacemaker in situ 

Answer: The patient is high likely exposed to